Safety and Efficacy of Mexidol® for ADHD in Children Aged 6-12

Clinical trial NCT06854601 · COMPLETED

Trial details

NCT number: NCT06854601
Sponsor: Pharmasoft
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder (ADHD)Anxiety Disorders and Symptoms

Start date: 2019-07-13
Primary completion: 2020-07-13
Enrollment: 333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.